413 related articles for article (PubMed ID: 18702958)
21. Comparing the efficacy of α-glucosidase inhibitors in suppressing postprandial hyperglycemia using continuous glucose monitoring: a pilot study-the MAJOR study.
Tsujino D; Nishimura R; Taki K; Morimoto A; Tajima N; Utsunomiya K
Diabetes Technol Ther; 2011 Mar; 13(3):303-8. PubMed ID: 21291335
[TBL] [Abstract][Full Text] [Related]
22. Postprandial serum lipids and tissue lipoprotein lipase are acutely altered in rats by the alpha-glucosidase inhibitor acarbose.
Picard F; Deshaies Y
Horm Metab Res; 1996 Aug; 28(8):377-80. PubMed ID: 8886823
[TBL] [Abstract][Full Text] [Related]
23. Acarbose lowers serum triglyceride and postprandial chylomicron levels in type 2 diabetes.
Ogawa S; Takeuchi K; Ito S
Diabetes Obes Metab; 2004 Sep; 6(5):384-90. PubMed ID: 15287932
[TBL] [Abstract][Full Text] [Related]
24. Postprandial variations of plasma inflammatory markers in abdominally obese men.
Blackburn P; Després JP; Lamarche B; Tremblay A; Bergeron J; Lemieux I; Couillard C
Obesity (Silver Spring); 2006 Oct; 14(10):1747-54. PubMed ID: 17062804
[TBL] [Abstract][Full Text] [Related]
25. Miglitol increases the adiponectin level and decreases urinary albumin excretion in patients with type 2 diabetes mellitus.
Yokoyama H; Kannno S; Ishimura I; Node K
Metabolism; 2007 Nov; 56(11):1458-63. PubMed ID: 17950094
[TBL] [Abstract][Full Text] [Related]
26. Postprandial glucose, insulin and glucagon-like peptide 1 responses to sucrose ingested with berries in healthy subjects.
Törrönen R; Sarkkinen E; Niskanen T; Tapola N; Kilpi K; Niskanen L
Br J Nutr; 2012 May; 107(10):1445-51. PubMed ID: 21929838
[TBL] [Abstract][Full Text] [Related]
27. Long-term effect of alpha-glucosidase inhibitor on late dumping syndrome.
Hasegawa T; Yoneda M; Nakamura K; Ohnishi K; Harada H; Kyouda T; Yoshida Y; Makino I
J Gastroenterol Hepatol; 1998 Dec; 13(12):1201-6. PubMed ID: 9918426
[TBL] [Abstract][Full Text] [Related]
28. Treating postprandial hyperglycemia does not appear to delay progression of early type 2 diabetes: the Early Diabetes Intervention Program.
Kirkman MS; Shankar RR; Shankar S; Shen C; Brizendine E; Baron A; McGill J
Diabetes Care; 2006 Sep; 29(9):2095-101. PubMed ID: 16936159
[TBL] [Abstract][Full Text] [Related]
29. Nutrient regulation of post-heparin lipoprotein lipase activity in obese subjects.
Ranganath LR; Beety JM; Wright J; Morgan LM
Horm Metab Res; 2001 Jan; 33(1):57-61. PubMed ID: 11280717
[TBL] [Abstract][Full Text] [Related]
30. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
Svendsen PF; Nilas L; Madsbad S; Holst JJ
Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
[TBL] [Abstract][Full Text] [Related]
31. Use of acarbose for eliminating the interval between meal consumption and insulin injection in patients with Type 1 diabetes.
Koch HH; Wudy A; Eberlein G; Quast C
Diabetes Nutr Metab; 1999 Jun; 12(3):195-201. PubMed ID: 10554902
[TBL] [Abstract][Full Text] [Related]
32. Effects of thorough mastication on postprandial plasma glucose concentrations in nonobese Japanese subjects.
Suzuki H; Fukushima M; Okamoto S; Takahashi O; Shimbo T; Kurose T; Yamada Y; Inagaki N; Seino Y; Fukui T
Metabolism; 2005 Dec; 54(12):1593-9. PubMed ID: 16311091
[TBL] [Abstract][Full Text] [Related]
33. Acarbose, an alpha-glucosidase inhibitor, improves endothelial dysfunction in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation.
Azuma K; Toyofuku Y; Iesaki T; Otsuka A; Tanaka A; Mita T; Hirose T; Tanaka Y; Daida H; Kawamori R; Watada H
Biochem Biophys Res Commun; 2006 Jun; 345(2):688-93. PubMed ID: 16696939
[TBL] [Abstract][Full Text] [Related]
34. Appetite hormones and energy intake in obese men after consumption of fructose, glucose and whey protein beverages.
Bowen J; Noakes M; Clifton PM
Int J Obes (Lond); 2007 Nov; 31(11):1696-703. PubMed ID: 17593904
[TBL] [Abstract][Full Text] [Related]
35. Glucagon-like peptide-1 (7-36) amide response to low versus high glycaemic index preloads in overweight subjects with and without type II diabetes mellitus.
Milton JE; Sananthanan CS; Patterson M; Ghatei MA; Bloom SR; Frost GS
Eur J Clin Nutr; 2007 Dec; 61(12):1364-72. PubMed ID: 17299480
[TBL] [Abstract][Full Text] [Related]
36. Anorexigenic effects of miglitol in concert with the alterations of gut hormone secretion and gastric emptying in healthy subjects.
Kaku H; Tajiri Y; Yamada K
Horm Metab Res; 2012 Apr; 44(4):312-8. PubMed ID: 22351480
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of α-glucosidase inhibitors on postprandial plasma glucose and lipid profile in patients with type 2 diabetes under control with insulin lispro mix 50/50.
Kimura T; Suzuki J; Ichikawa M; Imagawa M; Sato S; Fujii M; Zenimaru Y; Inaba S; Takahashi S; Konoshita T; Miyamori I
Diabetes Technol Ther; 2012 Jul; 14(7):545-51. PubMed ID: 22519736
[TBL] [Abstract][Full Text] [Related]
38. Effect of raisin consumption on oxidative stress and inflammation in obesity.
Rankin JW; Andreae MC; Oliver Chen CY; O'Keefe SF
Diabetes Obes Metab; 2008 Nov; 10(11):1086-96. PubMed ID: 18355330
[TBL] [Abstract][Full Text] [Related]
39. A case of insulinoma following total gastrectomy--effects of an alpha-glucosidase inhibitor on suppressing GIP and GLP-1 elevations.
Sato T; Narita T; Hosoba M; Kakei M; Nanjo H; Uchinami H; Satoh K; Yamamoto Y; Yamada Y
Diabetes Res Clin Pract; 2010 Apr; 88(1):e4-6. PubMed ID: 20122751
[TBL] [Abstract][Full Text] [Related]
40. The α-glucosidase inhibitor miglitol decreases glucose fluctuations and inflammatory cytokine gene expression in peripheral leukocytes of Japanese patients with type 2 diabetes mellitus.
Osonoi T; Saito M; Mochizuki K; Fukaya N; Muramatsu T; Inoue S; Fuchigami M; Goda T
Metabolism; 2010 Dec; 59(12):1816-22. PubMed ID: 20667563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
